{"@id":"https://bioecon.ru/technology/aav-retinal-gene-therapy/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://en.bioecon.ru/technology/aav-retinal-gene-therapy/","json":"https://en.bioecon.ru/api/v1/technology/aav-retinal-gene-therapy/index.json"},"id":"aav-retinal-gene-therapy","industries":["pharma","biomanufacturing"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/cryoport-systems/","https://bioecon.ru/companies/minicircle/","https://bioecon.ru/companies/kheiron-biotech/","https://bioecon.ru/companies/bioviva/","https://bioecon.ru/companies/pbs-biotech/","https://bioecon.ru/companies/anft-association-of-nature-forest-therapy/","https://bioecon.ru/companies/becton-dickinson/"]},"maturity":7,"name":"AAV Retinal Gene Therapy","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Capsid retinal tropism evolution"},{"n":2,"title":"Subretinal micro-cannulation"},{"n":3,"title":"Cell-type restricted promoter design"},{"n":4,"title":"Electroretinography visual recovery"}],"summary":"Engineered adeno-associated viral (AAV) capsids optimized for subretinal and intravitreal delivery directly into photoreceptors and retinal pigment epithelial (RPE) cells, delivering curative functional transgenes for inherited retinal dystrophies without ocular immune flares.","url":"/technology/aav-retinal-gene-therapy/","verified":"2026-11-22"}